MELISSA URANKER: Open Payments
NPI 1952775462 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,565 in 90 payments from 19 companies in 2025. Trend: 2023 $1,319 · 2024 $2,482 · 2025 $2,565
Food & beverage: $2,565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $431 |
| Galderma Laboratories, L.P. | 5 | $293 |
| Botanix SB Inc | 6 | $215 |
| Novartis Pharmaceuticals Corporation | 9 | $185 |
| Amgen Inc. | 7 | $159 |
| Janssen Biotech, Inc. | 6 | $157 |
| Lilly USA, LLC | 6 | $154 |
| Organon LLC | 5 | $137 |
| Incyte Corporation | 6 | $132 |
| PFIZER INC. | 1 | $121 |
Products named: SKYRIZI, NEMLUVIO, SOFDRA, DUPIXENT, OTEZLA, TREMFYA, OPZELURA, LITFULO.
Industry payments across FL — which companies pay providers there.
